Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Describe the Safety and Effectiveness of Venetoclax in Acute Myeloid Leukemia (AML) Patients (REVIVE Study)
Sponsor: AbbVie
Summary
This study will describe the safety and effectiveness of venetoclax in AML patients in routine clinical practice in Israel. The decision to treat with venetoclax is made by the physician prior to any decision regarding participation in this study.
Official title: Prospective Non-interventional Study to Describe the Effectiveness and Safety of Venetoclax in Acute Myeloid Leukemia (AML) Patients in Routine Clinical Practice (REVIVE Study)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
100
Start Date
2019-08-08
Completion Date
2027-07
Last Updated
2026-01-16
Healthy Volunteers
No
Conditions
Locations (12)
Meir Medical Center /ID# 213352
Kfar Saba, Central District, Israel
Assuta Tel Aviv Medical Center /ID# 213371
Tel Aviv, Central District, Israel
HaEmek Medical Center /ID# 213370
Afula, Haifa District, Israel
Shaare Zedek Medical Center /ID# 228016
Jerusalem, Jerusalem, Israel
Hadassah /ID# 213356
Jerusalem, Jerusalem, Israel
ZIV Medical Center /ID# 229211
Safed, Northern District, Israel
Soroka University Medical Center /ID# 213369
Beersheba, Southern District, Israel
The Chaim Sheba Medical Center /ID# 213353
Ramat Gan, Tel Aviv, Israel
Tel Aviv Sourasky Medical Center /ID# 213354
Tel Aviv, Tel Aviv, Israel
Rambam Health Care Campus /ID# 213355
Haifa, Israel
Bnai Zion Medical Center /ID# 213344
Haifa, Israel
Rabin Medical Center. /ID# 213343
Petah Tikva, Israel